Acta Scientific Cancer Biology (ASCB)(ISSN: 2582-4473)

Research Article Volume 4 Issue 10

About Extended Lymph-Node Dissection for Pancreatic Ductal Adenocarcinoma

Ramiz Bayramov

Professor at Department of Oncology, Azerbaijan Medical University, Baku, Azerbaijan

*Corresponding Author: Ramiz Bayramov, Professor at Department of Oncology, Azerbaijan Medical University, Baku, Azerbaijan.

Received: September 19, 2020; Published: September 29, 2020

×

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive malignant tumors in the human organism and is the most prevalent neoplastic disease of the pancreas accounting for approximately 90% of all pancreatic malignancies. To date, pancreatic cancer is the seventh most common cause of cancer-related deaths worldwide. The incidence of PDAC demonstrates annual 5 - 6% absolute increase worldwide and is expected to rise further in the future.

×

References

×

Citation

Citation: Ramiz Bayramov. “About Extended Lymph-Node Dissection for Pancreatic Ductal Adenocarcinoma”. Acta Scientific Cancer Biology 4.11 (2020): 01-03.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is November 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US